Skip Navigation
Jump to Main
Main navigation and Meta Navigation
To Home
Location Navigation
Edition Selection
Singapore Edition
International Edition
Meta Main Navigation
My News Feed
Bookmarks
Watch TV
Sign in
User Menu
Profile
My News Feed
My Topics
Bookmarks
Log out
Search
Open
All Sections
All Sections
Close
Section Navigation Title
CNA Lifestyle
CNA Insider
Singapore
Asia
World
Business
Sport
Technology
Health
Commentary
Podcasts
Video
Open
All Sections
Main Navigation
Section Navigation Title
Home
CNA Lifestyle
CNA Insider
Watch TV
Singapore Edition
International Edition
Compact Layout
All Sections
Close
Singapore
Asia
World
Business
Sport
Technology
Health
Commentary
Podcasts
Video
Singapore Parliament
Video Clips
Weather
PSI
Interactives
Special Reports
Remembering Aloysius Pang
Facebook
Twitter
LinkedIn
YouTube
RSS
Play Store
App Store
Search
Close Search
Search Term
Search Term
Clear search input
Search
Topic
close breaking news
amgen
Follow
Following
Displaying
10
out of
34
results
Health
Top US insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Business
Amgen quarterly profit tops Street view, 2019 forecast falls short
Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit as sales rose and tax expense fell, but competition for older medicines ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Health
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Health
Amgen's postmenopausal osteoporosis drug wins FDA panel backing
An advisory panel to the U.S. Food and Drug Administration on Wednesday recommended Amgen Inc's osteoporosis treatment for postmenopausal women at ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Business
Teva, Amgen end dispute over generic Cinacalcet HCl tablets
Teva Pharmaceutical Industries Ltd said on Thursday it will pay an undisclosed amount to settle an ongoing dispute with Amgen Inc over its ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Health
Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Business
Amgen quarterly profit beats Wall Street view on new product sales
Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year forecast, as growth of newer drugs like ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Health
Amgen's new migraine drug hits insurance hurdles
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Health
FDA approves Mylan's biosimilar to Neulasta
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Health
Novartis readies anti-sexism message for migraine drug
With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries ...
Toggle share menu
Share on Facebook
Share on Facebook
Share on Twitter
Share on Twitter
Share on LinkedIn
Share on LinkedIn
Share via Whatsapp
Share via Whatsapp
Share via E-Mail
Share via E-Mail
Explore results
{{pagination.index.feedback}}
1
of
4
NEXT